Injection fears and COVID-19 vaccine hesitancy. Issue 4 (11th March 2023)

• Record Type: Journal Article
• Authors: Freeman, Daniel; Lambe, Sinéad; Yu, Ly-Mee; Freeman, Jason; Chadwick, Andrew; Vaccari, Cristian; Waite, Felicity; Rosebrock, Laina; Petit, Ariane; Vanderslott, Samantha; Lewandowsky, Stephan; Larkin, Michael; Innocenti, Stefania; McShane, Helen; Pollard, Andrew J.; Loe, Bao Sheng
• Is Part Of: Psychological medicine. Volume 53:Issue 4(2023)
• Page Start: 1185
• Page End: 1195
• Publication Date: 2023-03-11
• Subjects: COVID-19 vaccine hesitancy -- needle fears -- blood-injection-injury phobia -- UK adults; Psychiatry -- Periodicals; Medicine and psychology -- Periodicals; Clinical psychology -- Periodicals; 616.89
• DOI: 10.1017/S0033291721002609
• Languages: English
• ISSNs: 0033-2917

Abstract

Abstract: Background: When vaccination depends on injection, it is plausible that the blood-injection-injury cluster of fears may contribute to hesitancy. Our primary aim was to estimate in the UK adult population the proportion of COVID-19 vaccine hesitancy explained by blood-injection-injury fears. Methods: In total, 15 014 UK adults, quota sampled to match the population for age, gender, ethnicity, income and region, took part (19 January–5 February 2021) in a non-probability online survey. The Oxford COVID-19 Vaccine Hesitancy Scale assessed intent to be vaccinated. Two scales (Specific Phobia Scale-blood-injection-injury phobia and Medical Fear Survey–injections and blood subscale) assessed blood-injection-injury fears. Four items from these scales were used to create a factor score specifically for injection fears. Results: In total, 3927 (26.2%) screened positive for blood-injection-injury phobia. Individuals screening positive (22.0%) were more likely to report COVID-19 vaccine hesitancy compared to individuals screening negative (11.5%), odds ratio = 2.18, 95% confidence interval (CI) 1.97–2.40, p < 0.001. The population attributable fraction (PAF) indicated that if blood-injection-injury phobia were absent then this may prevent 11.5% of all instances of vaccine hesitancy, AF = 0.11; 95% CI 0.09–0.14, p < 0.001. COVID-19 vaccine hesitancy was associated with higher scores on the Specific Phobia Scale, r = 0.22, p < 0.001, Medical Fear Survey, r = 0.23, p = <0.001 and injection fears, r = 0.25, p < 0.001. Injection fears were higher in youth and in Black and Asian ethnic groups, and explained a small degree of why vaccine hesitancy is higher in these groups. Conclusions: Across the adult population, blood-injection-injury fears may explain approximately 10% of cases of COVID-19 vaccine hesitancy. Addressing such fears will likely improve the effectiveness of vaccination programmes.